Experimental Conditions That Influence the Utility of 2′7′-Dichlorodihydrofluorescein Diacetate (DCFH2-DA) as a Fluorogenic Biosensor for Mitochondrial Redox Status
Open Access
- 22 July 2022
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 11 (8) , 1424
Abstract
Oxidative stress has been causally linked to various diseases. Electron transport chain (ETC) inhibitors such as rotenone and antimycin A are frequently used in model systems to study oxidative stress. Oxidative stress that is provoked by ETC inhibitors can be visualized using the fluorogenic probe 2′,7′-dichlorodihydrofluorescein-diacetate (DCFH2-DA). Non-fluorescent DCFH2-DA crosses the plasma membrane, is deacetylated to 2′,7′-dichlorodihydrofluorescein (DCFH2) by esterases, and is oxidized to its fluorescent form 2′,7′-dichlorofluorescein (DCF) by intracellular ROS. DCF fluorescence can, therefore, be used as a semi-quantitative measure of general oxidative stress. However, the use of DCFH2-DA is complicated by various protocol-related factors that mediate DCFH2-to-DCF conversion independently of the degree of oxidative stress. This study therefore analyzed the influence of ancillary factors on DCF formation in the context of ETC inhibitors. It was found that ETC inhibitors trigger DCF formation in cell-free experiments when they are co-dissolved with DCFH2-DA. Moreover, the extent of DCF formation depended on the type of culture medium that was used, the pH of the assay system, the presence of fetal calf serum, and the final DCFH2-DA solvent concentration. Conclusively, experiments with DCFH2-DA should not discount the influence of protocol-related factors such as medium and mitochondrial inhibitors (and possibly other compounds) on the DCFH2-DA-DCF reaction and proper controls should always be built into the assay protocol.Keywords
Funding Information
- KWF Kankerbestrijding (10666, Z20H160031, 81872220, LGF18H160034)
- Zhejiang Provincial Foreign Expert Program Grant, Zhejiang Provincial Key Natural Science Foundation of China (10666, Z20H160031, 81872220, LGF18H160034)
- Jiaxing Key Laboratory for Photonanomedicine and Experimental Therapeutics (10666, Z20H160031, 81872220, LGF18H160034)
- National Natural Science Foundation (10666, Z20H160031, 81872220, LGF18H160034)
- Basic Public Welfare Research Project of Zhejiang Province (10666, Z20H160031, 81872220, LGF18H160034)
- Tumor Nanotargeting and TCM Technology Innovation Team (Key Science and Technology Innovation Team of Jiaxing, 2018) (10666, Z20H160031, 81872220, LGF18H160034)
This publication has 125 references indexed in Scilit:
- Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancersJournal of Hematology & Oncology, 2013
- Control of Reactive Oxygen Species Production in Contracting Skeletal MuscleAntioxidants & Redox Signaling, 2011
- The Induction of MicroRNA Targeting IRS-1 Is Involved in the Development of Insulin Resistance under Conditions of Mitochondrial Dysfunction in HepatocytesPLOS ONE, 2011
- Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson’s disease modelJournal of Cell Biology, 2011
- Variable responses of small and large human hepatocytes to hypoxia and hypoxia/reoxygenation (H-R)FEBS Letters, 2011
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Reduction of Hydrophilic Ubiquinones by the Flavin in Mitochondrial NADH:Ubiquinone Oxidoreductase (Complex I) and Production of Reactive Oxygen SpeciesBiochemistry, 2009
- How mitochondria produce reactive oxygen speciesBiochemical Journal, 2008
- Selective fluorescent imaging of superoxide in vivo using ethidium-based probesProceedings of the National Academy of Sciences, 2006
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993